Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 85
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Semin Thromb Hemost ; 49(8): 785-796, 2023 Nov.
Article in English | MEDLINE | ID: mdl-37696292

ABSTRACT

High-risk acute pulmonary embolism (PE), defined as acute PE associated with hemodynamic instability, remains a significant contributor to cardiovascular morbidity and mortality in the United States and worldwide. Historically, anticoagulant therapy in addition to systemic thrombolysis has been the mainstays of medical therapy for the majority of patients with high-risk PE. In efforts to reduce the morbidity and mortality, a wide array of interventional and surgical therapies has been developed and employed in the management of these patients. However, the most recent guidelines for the management of PE have reserved the use of these advanced therapies in scenarios where thrombolytic therapy plus anticoagulation are unsuccessful. This is due largely to the lack of prospective, randomized studies in this population. Stemming from this, the approach to treatment of these patients varies widely depending on institutional experience and resources. Furthermore, morbidity and mortality remain unacceptably high in this population, with estimated 30-day mortality of at least 30%. As such, development of a standardized approach to treatment of these patients is paramount to improving outcomes. Early and accurate risk stratification in conjunction with a multidisciplinary team approach in the form of a PE response team is crucial. With the advent of novel therapies for the treatment of acute PE, in addition to the growing availability of and familiarity with mechanical circulatory support systems, such a standardized approach may now be within reach.


Subject(s)
Pulmonary Embolism , Thrombolytic Therapy , Humans , Follow-Up Studies , Acute Disease , Pulmonary Embolism/therapy , Pulmonary Embolism/drug therapy , Anticoagulants/therapeutic use , Treatment Outcome
2.
Heart Fail Clin ; 19(1): 67-73, 2023 Jan.
Article in English | MEDLINE | ID: mdl-36435574

ABSTRACT

Pulmonary embolism (PE) is a very common clinical entity with clinical symptoms that range from no symptom to complete hemodynamic collapse, sometimes with similar-appearing clot burden on computed tomographic pulmonary angiogram. Given highly variable clinical presentation, the authors wanted to investigate if there is clinical correlation based on the age of a clot with microscopic examination to clinical presentation. Thirteen thrombectomy aspirates from patients with an acute PE were microscopically analyzed. The goal was to age the thrombus based on histologic features and correlate it to clinical course.


Subject(s)
Pulmonary Embolism , Thrombosis , Humans , Pulmonary Embolism/diagnostic imaging , Pulmonary Embolism/surgery , Embolectomy , Thrombectomy/methods , Thrombosis/diagnostic imaging , Acute Disease
3.
Crit Care Med ; 49(5): 760-769, 2021 05 01.
Article in English | MEDLINE | ID: mdl-33590996

ABSTRACT

OBJECTIVE: Management of patients experiencing massive pulmonary embolism-related cardiac arrest is controversial. Venoarterial extracorporeal membranous oxygenation has emerged as a potential therapeutic option for these patients. We performed a systematic review assessing survival and predictors of mortality in patients with massive PE-related cardiac arrest with venoarterial extracorporeal membranous oxygenation use. DATA SOURCES: A literature search was started on February 16, 2020, and completed on March 16, 2020, using PubMed, Embase, Cochrane Central, Cinahl, and Web of Science. STUDY SELECTION: We included all available literature that reported survival to discharge in patients managed with venoarterial extracorporeal membranous oxygenation for massive PE-related cardiac arrest. DATA EXTRACTION: We extracted patient characteristics, treatment details, and outcomes. DATA SYNTHESIS: About 301 patients were included in our systemic review from 77 selected articles (total screened, n = 1,115). About 183 out of 301 patients (61%) survived to discharge. Patients (n = 51) who received systemic thrombolysis prior to cannulation had similar survival compared with patients who did not (67% vs 61%, respectively; p = 0.48). There was no significant difference in risk of death if PE was the primary reason for admission or not (odds ratio, 1.62; p = 0.35) and if extracorporeal membranous oxygenation cannulation occurred in the emergency department versus other hospital locations (odds ratio, 2.52; p = 0.16). About 53 of 60 patients (88%) were neurologically intact at discharge or follow-up. Multivariate analysis demonstrated three-fold increase in the risk of death for patients greater than 65 years old (adjusted odds ratio, 3.08; p = 0.03) and six-fold increase if cannulation occurred during cardiopulmonary resuscitation (adjusted odds ratio, 5.67; p = 0.03). CONCLUSIONS: Venoarterial extracorporeal membranous oxygenation has an emerging role in the management of massive PE-related cardiac arrest with 61% survival. Systemic thrombolysis preceding venoarterial extracorporeal membranous oxygenation did not confer a statistically significant increase in risk of death, yet age greater than 65 and cannulation during cardiopulmonary resuscitation were associated with a three- and six-fold risks of death, respectively.


Subject(s)
Cardiopulmonary Resuscitation/methods , Extracorporeal Membrane Oxygenation/methods , Heart Arrest/therapy , Pulmonary Embolism/therapy , Cardiopulmonary Resuscitation/mortality , Extracorporeal Membrane Oxygenation/mortality , Heart Arrest/complications , Heart Arrest/mortality , Humans , Patient Discharge/statistics & numerical data , Pulmonary Embolism/etiology , Pulmonary Embolism/mortality , Risk Factors , Survival Rate
4.
Semin Respir Crit Care Med ; 42(2): 183-198, 2021 04.
Article in English | MEDLINE | ID: mdl-33548934

ABSTRACT

Pulmonary embolism (PE) is a common clinical entity, which most clinicians will encounter. Appropriate risk stratification of patients is key to identify those who may benefit from reperfusion therapy. The first step in risk assessment should be the identification of hemodynamic instability and, if present, urgent patient consideration for systemic thrombolytics. In the absence of shock, there is a plethora of imaging studies, biochemical markers, and clinical scores that can be used to further assess the patients' short-term mortality risk. Integrated prediction models incorporate more information toward an individualized and precise mortality prediction. Additionally, bleeding risk scores should be utilized prior to initiation of anticoagulation and/or reperfusion therapy administration. Here, we review the latest algorithms for a comprehensive risk stratification of the patient with acute PE.


Subject(s)
Pulmonary Embolism , Acute Disease , Algorithms , Fibrinolytic Agents/therapeutic use , Humans , Pulmonary Embolism/drug therapy , Pulmonary Embolism/therapy , Risk Assessment , Thrombolytic Therapy
5.
Eur Respir J ; 2020 Jul 23.
Article in English | MEDLINE | ID: mdl-32703772

ABSTRACT

BACKGROUND: Improved prediction of the risk of major bleeding in patients with acute pulmonary embolism (PE) receiving systemic thrombolysis is crucial to guide the choice of therapy. METHODS: The study included consecutive patients with acute PE who received systemic thrombolysis in the RIETE registry. We used multivariable logistic regression analysis to create a risk score to predict 30-day major bleeding episodes. We externally validated the risk score in patients from the COMMAND VTE registry. We also compared the newly created risk score against the Kuijer and RIETE scores. RESULTS: Multivariable logistic regression identified four predictors for major bleeding: recent major Bleeding (3 points), Age >75 years (1 point), active Cancer (1 point), and Syncope (1 point) (BACS). Among 1172 patients receiving thrombolytic therapy in RIETE, 446 (38%) were classified as having low-risk (none of the variables present, 0 points) of major bleeding according to the BACS score, and the overall 30-day major bleeding rate of this group was 2.9% (95% CI, 1.6-4.9%), compared with 44% (95% CI, 14-79%) in the high-risk group (>3 points). In the validation cohort, 51% (149/290) of patients were classified as having low-risk, and the overall 30-day major bleeding rate of this group was 1.3%. In RIETE, the 30-day major bleeding event rates in the Kuijer and RIETE low-risk stratum were 5.3% and 4.4%, respectively. CONCLUSIONS: The BACS score is an easily applicable aid for prediction of the risk of major bleeding in the population of PE patients who receive systemic thrombolysis.

6.
Emerg Radiol ; 27(4): 433-439, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32211984

ABSTRACT

High-risk PE can be complicated by the presence of a patent foramen ovale (PFO), which can lead to paradoxical systemic embolization, including cerebral embolism ultimately leading to acute ischemic stroke (AIS). Acute management is challenging given the competing benefits and risks of systemic thrombolysis. Herein, we aim to provide a review of clinical presentations, diagnostic findings, and treatment and outcome from the available literature, with the hopes of providing insight into treatment options. We followed the guidelines outlined by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). A systematic literature search using PubMed/MEDLINE database, Cochrane Library, and Google Scholar for all reported cases/case series of concomitant high-risk PE and paradoxical ischemic stroke was conducted from inception to July 2019. Twenty-nine cases from 27 articles (26 single case reports, 1 case series of 3 patients) were included. There were 10 men and 19 women, ranging in age from 29 to 81 years (mean 56.1 ± 13.5 years). PFO was diagnosed in 89.7% of patients, mostly by transesophageal echocardiography. Treatment modalities included systemic thrombolysis (40%), anticoagulation alone (36%), surgical thrombectomy (16%), and percutaneous thrombectomy (8%). Overall mortality rate was 31%. Patients receiving thrombolysis and surgical thrombectomy had the most favorable outcome. Survival to discharge was 90% (9 out of 10), 100% (5 out of 5), and 50% (4 out of 8) in the systemic thrombolysis, surgical thrombectomy, and anticoagulation alone groups respectively. In the setting of combined high-risk PE and ischemic stroke, PFO can be detected in 90% of published cases. Thrombolysis and surgical thrombectomy seem to be effective management, but further studies are needed for validation.


Subject(s)
Embolism, Paradoxical/diagnostic imaging , Foramen Ovale, Patent/diagnostic imaging , Ischemic Stroke/diagnostic imaging , Pulmonary Embolism/diagnostic imaging , Diagnosis, Differential , Embolism, Paradoxical/therapy , Foramen Ovale, Patent/therapy , Humans , Ischemic Stroke/therapy , Pulmonary Embolism/therapy
7.
Am J Respir Crit Care Med ; 198(5): 588-598, 2018 09 01.
Article in English | MEDLINE | ID: mdl-29672125

ABSTRACT

Pulmonary embolism (PE) presents a spectrum of hemodynamic consequences, ranging from being asymptomatic to a life-threatening medical emergency. Management of submassive and massive PE often involves clinicians from multiple specialties, which can potentially delay the development of a unified treatment plan. In addition, patients with submassive PE can deteriorate after their presentation and require escalation of care. Underlying comorbidities such as chronic obstructive pulmonary disease, cancer, congestive heart failure, and interstitial lung disease can impact the patient's hemodynamic ability to tolerate submassive PE. In this review, we address the definitions, risk stratification (clinical, laboratory, and imaging), management approaches, and long-term outcomes of submassive PE. We also discuss the role of the PE response team in management of patients with PE.


Subject(s)
Pulmonary Embolism/diagnosis , Pulmonary Embolism/physiopathology , Computed Tomography Angiography , Embolectomy , Humans , Pulmonary Artery/diagnostic imaging , Pulmonary Artery/physiopathology , Pulmonary Embolism/therapy , Severity of Illness Index , Vena Cava Filters
10.
Conn Med ; 81(1): 27-29, 2017 Jan.
Article in English | MEDLINE | ID: mdl-29782763

ABSTRACT

Leiomyosarcomas of vascular origin are extremely rare malignant tumors that can present a diagnostic challenge when they present as a mediastinal mass. Although they portend a poor prognosis with both aggressive local symptoms and metastatic disease, we present a rare case in which surgical en bloc resection of the tumor was curative.


Subject(s)
Brachiocephalic Veins/pathology , Leiomyosarcoma/diagnosis , Muscle, Smooth/pathology , Aged , Humans , Leiomyosarcoma/pathology , Leiomyosarcoma/surgery , Male , Prognosis , Treatment Outcome
11.
Crit Care Med ; 49(12): e1264-e1265, 2021 12 01.
Article in English | MEDLINE | ID: mdl-34793393
13.
Crit Care Nurs Q ; 39(2): 131-8, 2016.
Article in English | MEDLINE | ID: mdl-26919674

ABSTRACT

Pulmonary embolism covers a wide spectrum of presentation from an asymptomatic individual to a life-threatening medical emergency. It is of paramount importance to appropriately risk stratify patients with pulmonary embolism, particularly with those who present without hypotension. Right ventricular dysfunction can evolve after a patient has received a diagnosis of pulmonary embolism, necessitating aggressive measures rather than simple anticoagulation. In this review, we discuss definition, risk stratification, pathogenesis, diagnostic approach, and management, with particular focus on massive pulmonary embolism.


Subject(s)
Pulmonary Embolism , Anticoagulants/therapeutic use , Biomarkers/blood , Embolectomy , Humans , Pulmonary Embolism/diagnosis , Pulmonary Embolism/therapy , Risk Assessment , Thrombolytic Therapy , Ventricular Dysfunction, Right/diagnosis
14.
Crit Care Nurs Q ; 39(2): 139-47, 2016.
Article in English | MEDLINE | ID: mdl-26919675

ABSTRACT

Hemoptysis, or coughing of blood, oftentimes triggers anxiety and fear for patients. The etiology of hemoptysis will determine the clinical course, which includes watchful waiting or intensive care admission. Any amount of hemoptysis that compromises the patient's respiratory status is considered massive hemoptysis and should be considered a medical emergency. In this article, we review introduction, definition, bronchial circulation anatomy, etiology, and management of massive hemoptysis.


Subject(s)
Hemodynamics , Hemoptysis/etiology , Hemoptysis/therapy , Bronchoscopy/methods , Critical Care , Emergencies , Hemoptysis/diagnosis , Humans
15.
Crit Care Nurs Q ; 39(2): 161-75, 2016.
Article in English | MEDLINE | ID: mdl-26919677

ABSTRACT

Infections that are typically innocuous in immunocompetent persons may cause significant disease states in immunocompromised hosts. These individuals may be immunosuppressed secondary to many different causes such as drugs, malignancy, solid-organ or hematopoietic stem cell transplantation, HIV/AIDS, or anatomic reasons (asplenia). These immunocompromised hosts are at high risk for developing opportunistic infections. Here, we discuss some of these infections caused by bacteria, fungi, viruses, and parasites. Clinicians should be aware of the risk factors, common clinical presentations, diagnostic modalities, and treatment options for these potentially fatal illnesses.


Subject(s)
Immunocompromised Host , Opportunistic Infections/diagnosis , Opportunistic Infections/microbiology , Bacterial Infections/diagnosis , Humans , Lung Diseases, Fungal/diagnosis , Opportunistic Infections/immunology , Risk Factors
16.
Conn Med ; 80(7): 423-425, 2016 Sep.
Article in English | MEDLINE | ID: mdl-29782132

ABSTRACT

We present a case of spontaneous rupture of the diaphragm in a young pregnant female mimicking hydropneumothorax. She had a chest tube placed on admission without any improvement in her symptoms, which led to further imaging. Chest and abdomen CT after a barium swallow confirmed the clinical diagnosis. She had definitive surgical repair followed by an uneventful clinical recovery.


Subject(s)
Diaphragm , Hydropneumothorax/diagnosis , Laparotomy/methods , Thoracostomy/methods , Abortion, Spontaneous/therapy , Adult , Diaphragm/diagnostic imaging , Diaphragm/pathology , Diaphragm/physiopathology , Female , Humans , Pregnancy , Radiographic Image Enhancement/methods , Radiography, Thoracic/methods , Rupture, Spontaneous/diagnosis , Rupture, Spontaneous/diagnostic imaging , Rupture, Spontaneous/physiopathology , Rupture, Spontaneous/surgery , Suture Techniques , Tomography, X-Ray Computed/methods , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL